These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36690972)

  • 1. AI-based dimensional neuroimaging system for characterizing heterogeneity in brain structure and function in major depressive disorder: COORDINATE-MDD consortium design and rationale.
    Fu CHY; Erus G; Fan Y; Antoniades M; Arnone D; Arnott SR; Chen T; Choi KS; Fatt CC; Frey BN; Frokjaer VG; Ganz M; Garcia J; Godlewska BR; Hassel S; Ho K; McIntosh AM; Qin K; Rotzinger S; Sacchet MD; Savitz J; Shou H; Singh A; Stolicyn A; Strigo I; Strother SC; Tosun D; Victor TA; Wei D; Wise T; Woodham RD; Zahn R; Anderson IM; Deakin JFW; Dunlop BW; Elliott R; Gong Q; Gotlib IH; Harmer CJ; Kennedy SH; Knudsen GM; Mayberg HS; Paulus MP; Qiu J; Trivedi MH; Whalley HC; Yan CG; Young AH; Davatzikos C
    BMC Psychiatry; 2023 Jan; 23(1):59. PubMed ID: 36690972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MarkVCID cerebral small vessel consortium: II. Neuroimaging protocols.
    Lu H; Kashani AH; Arfanakis K; Caprihan A; DeCarli C; Gold BT; Li Y; Maillard P; Satizabal CL; Stables L; Wang DJJ; Corriveau RA; Singh H; Smith EE; Fischl B; van der Kouwe A; Schwab K; Helmer KG; Greenberg SM;
    Alzheimers Dement; 2021 Apr; 17(4):716-725. PubMed ID: 33480157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using graph convolutional network to characterize individuals with major depressive disorder across multiple imaging sites.
    Qin K; Lei D; Pinaya WHL; Pan N; Li W; Zhu Z; Sweeney JA; Mechelli A; Gong Q
    EBioMedicine; 2022 Apr; 78():103977. PubMed ID: 35367775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotypes of major depressive disorder: Neuroimaging evidence from resting-state default mode network patterns.
    Liang S; Deng W; Li X; Greenshaw AJ; Wang Q; Li M; Ma X; Bai TJ; Bo QJ; Cao J; Chen GM; Chen W; Cheng C; Cheng YQ; Cui XL; Duan J; Fang YR; Gong QY; Guo WB; Hou ZH; Hu L; Kuang L; Li F; Li KM; Liu YS; Liu ZN; Long YC; Luo QH; Meng HQ; Peng DH; Qiu HT; Qiu J; Shen YD; Shi YS; Si TM; Wang CY; Wang F; Wang K; Wang L; Wang X; Wang Y; Wu XP; Wu XR; Xie CM; Xie GR; Xie HY; Xie P; Xu XF; Yang H; Yang J; Yu H; Yao JS; Yao SQ; Yin YY; Yuan YG; Zang YF; Zhang AX; Zhang H; Zhang KR; Zhang ZJ; Zhao JP; Zhou RB; Zhou YT; Zou CJ; Zuo XN; Yan CG; Li T
    Neuroimage Clin; 2020; 28():102514. PubMed ID: 33396001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal functional and structural neuroimaging investigation of major depressive disorder following treatment with duloxetine.
    Fu CH; Costafreda SG; Sankar A; Adams TM; Rasenick MM; Liu P; Donati R; Maglanoc LA; Horton P; Marangell LB
    BMC Psychiatry; 2015 Apr; 15():82. PubMed ID: 25880400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualized Functional Connectome Identified Replicable Biomarkers for Dysphoric Symptoms in First-Episode Medication-Naïve Patients With Major Depressive Disorder.
    Zhao Y; Dahmani L; Li M; Hu Y; Ren J; Lui S; Wang D; Kuang W; Gong Q; Liu H
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2023 Jan; 8(1):42-51. PubMed ID: 34995770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of Major Depressive Disorder Using Machine Learning Based on Multisequence MRI Neuroimaging Features.
    Li Q; Dong F; Gai Q; Che K; Ma H; Zhao F; Chu T; Mao N; Wang P
    J Magn Reson Imaging; 2023 Nov; 58(5):1420-1430. PubMed ID: 36797655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated classification of depression from structural brain measures across two independent community-based cohorts.
    Stolicyn A; Harris MA; Shen X; Barbu MC; Adams MJ; Hawkins EL; de Nooij L; Yeung HW; Murray AD; Lawrie SM; Steele JD; McIntosh AM; Whalley HC
    Hum Brain Mapp; 2020 Oct; 41(14):3922-3937. PubMed ID: 32558996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-alteration Network Architecture of Major Depressive Disorder: A Multi-modal Neuroimaging Assessment of Large-scale Disease Effects.
    Gray JP; Manuello J; Alexander-Bloch AF; Leonardo C; Franklin C; Choi KS; Cauda F; Costa T; Blangero J; Glahn DC; Mayberg HS; Fox PT
    Neuroinformatics; 2023 Apr; 21(2):443-455. PubMed ID: 36469193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.
    Wilcock D; Jicha G; Blacker D; Albert MS; D'Orazio LM; Elahi FM; Fornage M; Hinman JD; Knoefel J; Kramer J; Kryscio RJ; Lamar M; Moghekar A; Prestopnik J; Ringman JM; Rosenberg G; Sagare A; Satizabal CL; Schneider J; Seshadri S; Sur S; Tracy RP; Yasar S; Williams V; Singh H; Mazina L; Helmer KG; Corriveau RA; Schwab K; Kivisäkk P; Greenberg SM;
    Alzheimers Dement; 2021 Apr; 17(4):704-715. PubMed ID: 33480172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients With Late-Life Depression.
    Wen J; Fu CHY; Tosun D; Veturi Y; Yang Z; Abdulkadir A; Mamourian E; Srinivasan D; Skampardoni I; Singh A; Nawani H; Bao J; Erus G; Shou H; Habes M; Doshi J; Varol E; Mackin RS; Sotiras A; Fan Y; Saykin AJ; Sheline YI; Shen L; Ritchie MD; Wolk DA; Albert M; Resnick SM; Davatzikos C;
    JAMA Psychiatry; 2022 May; 79(5):464-474. PubMed ID: 35262657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional connectivity signatures of major depressive disorder: machine learning analysis of two multicenter neuroimaging studies.
    Gallo S; El-Gazzar A; Zhutovsky P; Thomas RM; Javaheripour N; Li M; Bartova L; Bathula D; Dannlowski U; Davey C; Frodl T; Gotlib I; Grimm S; Grotegerd D; Hahn T; Hamilton PJ; Harrison BJ; Jansen A; Kircher T; Meyer B; Nenadić I; Olbrich S; Paul E; Pezawas L; Sacchet MD; Sämann P; Wagner G; Walter H; Walter M; ; van Wingen G
    Mol Psychiatry; 2023 Jul; 28(7):3013-3022. PubMed ID: 36792654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detecting Neuroimaging Biomarkers for Depression: A Meta-analysis of Multivariate Pattern Recognition Studies.
    Kambeitz J; Cabral C; Sacchet MD; Gotlib IH; Zahn R; Serpa MH; Walter M; Falkai P; Koutsouleris N
    Biol Psychiatry; 2017 Sep; 82(5):330-338. PubMed ID: 28110823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurobiological signatures of anxiety and depression in resting-state functional magnetic resonance imaging.
    Oathes DJ; Patenaude B; Schatzberg AF; Etkin A
    Biol Psychiatry; 2015 Feb; 77(4):385-93. PubMed ID: 25444162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vulnerability for new episodes in recurrent major depressive disorder: protocol for the longitudinal DELTA-neuroimaging cohort study.
    Mocking RJ; Figueroa CA; Rive MM; Geugies H; Servaas MN; Assies J; Koeter MW; Vaz FM; Wichers M; van Straalen JP; de Raedt R; Bockting CL; Harmer CJ; Schene AH; Ruhé HG
    BMJ Open; 2016 Mar; 6(3):e009510. PubMed ID: 26932139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinguishing medication-free subjects with unipolar disorder from subjects with bipolar disorder: state matters.
    Rive MM; Redlich R; Schmaal L; Marquand AF; Dannlowski U; Grotegerd D; Veltman DJ; Schene AH; Ruhé HG
    Bipolar Disord; 2016 Nov; 18(7):612-623. PubMed ID: 27870505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep phenotyping towards precision psychiatry of first-episode depression - the Brain Drugs-Depression cohort.
    Jensen KHR; Dam VH; Ganz M; Fisher PM; Ip CT; Sankar A; Marstrand-Joergensen MR; Ozenne B; Osler M; Penninx BWJH; Pinborg LH; Frokjaer VG; Knudsen GM; Jørgensen MB
    BMC Psychiatry; 2023 Mar; 23(1):151. PubMed ID: 36894940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and Predictive Neuroimaging Biomarkers for Posttraumatic Stress Disorder.
    Zilcha-Mano S; Zhu X; Suarez-Jimenez B; Pickover A; Tal S; Such S; Marohasy C; Chrisanthopoulos M; Salzman C; Lazarov A; Neria Y; Rutherford BR
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2020 Jul; 5(7):688-696. PubMed ID: 32507508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disrupted hemispheric connectivity specialization in patients with major depressive disorder: Evidence from the REST-meta-MDD Project.
    Ding YD; Yang R; Yan CG; Chen X; Bai TJ; Bo QJ; Chen GM; Chen NX; Chen TL; Chen W; Cheng C; Cheng YQ; Cui XL; Duan J; Fang YR; Gong QY; Hou ZH; Hu L; Kuang L; Li F; Li T; Liu YS; Liu ZN; Long YC; Luo QH; Meng HQ; Peng DH; Qiu HT; Qiu J; Shen YD; Shi YS; Tang Y; Wang CY; Wang F; Wang K; Wang L; Wang X; Wang Y; Wu XP; Wu XR; Xie CM; Xie GR; Xie HY; Xie P; Xu XF; Yang H; Yang J; Yao JS; Yao SQ; Yin YY; Yuan YG; Zhang AX; Zhang H; Zhang KR; Zhang L; Zhang ZJ; Zhou RB; Zhou YT; Zhu JJ; Zou CJ; Si TM; Zang YF; Zhao JP; Guo WB
    J Affect Disord; 2021 Apr; 284():217-228. PubMed ID: 33609956
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.